Monitor for the naming of a successor CFO. A prolonged vacancy or external hire could signal a strategic shift, while a smooth internal transition would be neutral. The stock is unlikely to react to this filing alone.
Price Chart
Executive Summary
Allogene Therapeutics disclosed the retirement of EVP and CFO Geoffrey Parker, effective November 6, 2026. No replacement has been named, creating a leadership gap in the finance function. This is a routine retirement notice for a C-suite officer, but the lack of a named successor introduces minor operational uncertainty for a clinical-stage biotech.
Key Facts
- EVP and CFO Geoffrey Parker announced retirement effective November 6, 2026.
- No replacement has been named as of the filing date.
- Parker's departure is framed as a retirement, not a resignation or termination.
Financial Impact
No financial impact disclosed; CFO transition costs are immaterial for a $686M market cap company.
Risk Factors
- CFO transition risk if no successor is named before the effective date.
- Potential distraction from pipeline execution during the search process.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-379423 |
| Document: 0001193125-26-379423-index-headers.html | 0001193125-26-379423 |
| Document: 0001193125-26-379423-index.html | 0001193125-26-379423 |
| Document: 0001193125-26-379423.txt | 0001193125-26-379423 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 144 | $1.25 $1.25 | · 0.00% | ▲ +0.52% | $1.23 (−1.60%) |
Sep 2, 2026 7w ago | 8-K | $1.98 $1.98 | · 0.00% | ▼ −1.05% | $1.23 (−37.88%) |
Aug 21, 2026 9w ago | 144 | $2.03 $2.17 | ▲ +6.90% | ▲ +6.58% | $1.23 (−39.41%) |
Aug 21, 2026 9w ago | EFFECT | $2.09 $2.03 | ▲ +2.87% | ▲ +2.58% | $1.23 (+41.15%) |
Aug 6, 2026 11w ago | Institutional Cluster | $1.97 $2.01 | ▲ +2.03% | ▲ +1.42% | $1.23 (−37.56%) |
Jun 22, 2026 18w ago | 8-K | $2.07 $2.05 | ▲ +0.97% | ▲ +0.92% | $1.23 (+40.58%) |
Jun 22, 2026 18w ago | 424B5 | $2.07 $2.05 | ▲ +0.97% | ▲ +0.92% | $1.23 (+40.58%) |
May 28, 2026 21w ago | DEFA14A | $2.17 $2.15 | ▼ −0.92% | ▼ −1.18% | $1.23 (−43.32%) |
May 28, 2026 21w ago | 8-K | $2.17 $2.15 | ▼ −0.92% | ▼ −1.18% | $1.23 (−43.32%) |
May 28, 2026 21w ago | Press Release | $2.17 $2.15 | ▼ −0.92% | ▼ −1.20% | $1.23 (−43.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers